Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment stopped in phase II of Velcade for metastatic colorectal cancer

Jan. 9, 2004

Update on Generex technologies

Jan. 9, 2004

Bayer scientists claim new pyrimidine-based antiproliferative agents

Jan. 9, 2004

Novel FAP-activated prodrugs with utility in cancer therapy

Jan. 9, 2004

Novel chemopreventive and chemotherapeutic agents identified at the U. of Mississippi

Jan. 8, 2004

French scientists describe new potentiators of antiplasmodial and antitumor agents

Jan. 8, 2004

New antitumor azoles in early development at Sankyo

Jan. 7, 2004

Mitsui Chemicals patent covers new agents for telomerase-mediated disorders

Jan. 7, 2004

Kirin Brewery presents new inhibitors of Bcl-2/Bcl-xL with utility in cancer therapy

Jan. 7, 2004

Pharmion submits Vidaza NDA

Jan. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.